Test Price
2,800 AED✅ Home Collection Available
HPCA Gene DYT2 Genetic Test in UAE | 2,800 AED | 2026 DHA Guidelines
تحليل جين HPCA (خلل التوتر العضلي الوراثي DYT2) بتقنية التسلسل الجيني الفائق (NGS) في الإمارات | 2800 درهم | معتمد من هيئة الصحة بدبي
🔬 Executive Summary – Guaranteed Precision
- 99.9% Diagnostic Sensitivity via ISO-Accredited NGS full-gene sequencing. (ضمان الدقة ٩٩.٩٪ تشخيصياً)
- VIP Home Collection: ISO-certified cold-chain mobile phlebotomy (8 AM – 11 PM, 7 days).
- Clinical Guidance: Post-test teleconsultation for result interpretation.
- Insurance Support: Direct billing verification via WhatsApp +971 54 548 8731.
📋 Key Compliance & Peace of Mind
- Federal Decree-Law No. 41 of 2024 (Art. 87) – Medical Liability
- UAE CDS Law 2026 – Minor Consent Protocols
- PDPL – Secure Genetic Data Handling
- ISO 9001:2015 (Cert: INT/EGQ/2509DA/3139)
Overview & Clinical Utility
The HPCA Gene DYT2 Genetic Test is a high-precision next-generation sequencing assay designed to detect pathogenic variants in the HPCA gene, which are causative for autosomal dominant dystonia type 2 (DYT2). This test is indispensable for neurologists and geneticists seeking definitive molecular diagnosis in patients with early-onset dystonia, especially when accompanied by a positive family history. (يُعد هذا الاختبار الجيني المتطور ضرورياً لتأكيد التشخيص السريري لخلل التوتر العضلي الوراثي وتقديم الإرشاد الوراثي للعائلات المعرضة).
| Feature | ⭐ Our Test (NGS Full HPCA Gene) | 🔍 Sanger Sequencing (Alternative) |
|---|---|---|
| Precision / Coverage | Complete coding region & splice sites; detects SNVs, indels, CNVs | Limited to targeted amplicon; miss copy-number variants |
| Turnaround Time | 3–4 weeks (ISO 15189-accredited lab) | 6–8 weeks (often outsourced) |
| Diagnostic Yield | >99.9% sensitivity for pathogenic variants | ~90% for point mutations only |
| Clinical Reporting | Curated with ACMG classification & clinical correlation note | Basic variant report without contextual phenotype |
Physician Insight & Safety Protocol
“As a neurologist practicing under DHA (License: 61713011), I emphasize that this genetic test is a powerful tool—but it must be interpreted within the full clinical picture. A positive HPCA variant confirms hereditary dystonia, yet a negative result does not exclude other dystonia genes; always correlate with electromyography, brain MRI, and family history. Guide your patients gently through the implications, as this knowledge can alter treatment planning and family dynamics.”
— Dr. Prabhakar Reddy, DHA-Certified Consultant Neurologist
⚠️ Medication Warning
Do not discontinue any prescribed medication (e.g., anticholinergics, botulinum toxin injections) without consulting your treating physician. Genetic results are supplementary and do not override clinical management.
🔴 Safety Exclusion Criteria & Emergency Red Flags
Exclusion Criteria (Do Not Proceed)
- Inability to provide informed consent or lack of legal guardian for minors.
- Recent blood transfusion (< 3 weeks) if submitting whole blood.
- Severe hemophilia or bleeding disorder without physician clearance.
- Known active infection with febrile illness (postpone collection).
Seek Immediate Medical Attention If:
- Sudden worsening of dystonia leading to airway compromise.
- Acute neck or trunk spasms causing difficulty breathing or swallowing.
- New onset of confusion, seizures, or suicidal ideation.
- Status dystonicus (prolonged, severe dystonic contractions).
Frequently Asked Questions (Clinical Guidance)
Q1: Who should undergo the HPCA gene DYT2 NGS test?
Snippet: The HPCA gene DYT2 NGS test is recommended for individuals with childhood- or adolescent-onset dystonia and a family history of movement disorders requiring molecular confirmation.
يُوصى بهذا الاختبار الجيني للمرضى الذين يعانون من خلل التوتر العضلي المبكر (في الطفولة أو المراهقة) مع وجود تاريخ عائلي مماثل، حيث يُساعد على تأكيد التشخيص وتحديد خطة العلاج والاستشارة الوراثية.
Q2: How is the sample collected and what is the turnaround time?
Snippet: A DHA-licensed phlebotomist collects a small blood sample or DNA FTA card at your home, and the final NGS report is securely delivered within 3 to 4 weeks.
يتم جمع العينة عبر خدمة السحب المنزلي المعتمدة من هيئة الصحة بدبي (عينة دم أو بطاقة الحمض النووي)، وتُصدر النتيجة المفصلة خلال 3 إلى 4 أسابيع عبر البوابة الإلكترونية الآمنة.
Q3: Is this covered by insurance in the UAE?
Snippet: Insurance coverage varies by plan; our team verifies direct billing eligibility and obtains pre‑approval using neurological genetic testing codes before your appointment.
يختلف نطاق التغطية التأمينية حسب وثيقتك؛ نتحقق مباشرة من إمكانية الفوترة المباشرة ونقوم بتأمين الموافقة المسبقة عبر كود الاختبارات الجينية العصبية المعتمدة قبل موعدك.
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians